Once daily Busulfan (Bu) and fludarabine (Flu) with allogeneic stem cell transplantation (AlloSCT) in acute myelogenous leukemia (AML) and myelodysplastic syndrome (MDS): Clinical results and pharmacokinetics.

被引：0
|
作者：
de Lima, M
Madden, T
Couriel, D
Thall, RF
Shahjahan, M
Giralt, S
Anderlini, P
Russell, J
Shpall, EJ
Champlin, RE
Andersson, BS
机构：
[1] Univ Texas, MD Anderson Canc Ctr, Dept Blood & Marrow Transplantation, Houston, TX 77030 USA
[2] MD Anderson Canc Ctr, Dept Blood & Marrow Transplantat, Houston, TX USA
来源：
BLOOD | 2003年 / 102卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2607
引用
收藏
页码：704A / 705A
页数：2
相关论文
共 50 条
  • [21] ALLOGENEIC STEM CELL TRANSPLANTATION (ALLO-SCT) FOR RELAPSED, REFRACTORY MYELOID LEUKEMIA AND MDS USING CLOFARABINE (CLO) ± FLUDARABINE (FLU) WITH IV BUSULFAN (BU) AS CONDITIONING THERAPY
    Andersson, B. S.
    de Lima, M.
    Popat, U.
    Jones, R. B.
    Shpall, E. J.
    Hosing, C.
    McAdams, P. L.
    Alousi, A. M.
    Kebriaei, P.
    Champlin, R. E.
    Worth, L. L.
    Madden, T. L.
    Kazerooni, R.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2009, 15 (02) : 86 - 87
  • [22] Outcomes of Allogeneic Stem Cell Transplantation (alloSCT) for Therapy-Related Acute Myeloid Leukemia and Myelodysplastic Syndrome
    Peker, Deniz
    Jamil, Muhammad Omer
    Salzman, Donna
    Jackson, Bradford E.
    Borate, Uma
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (03) : S346 - S347
  • [23] Transplantation outcomes of a once-daily intravenous Busulfan and Fludarabine conditioning for Allogeneic hematopoietic stem cell transplantation in pediatric AML and high risk MDS: Single center experience in Korea
    Lim, Y-T
    Yang, E-J
    Park, K-M
    BONE MARROW TRANSPLANTATION, 2017, 52 : S514 - S514
  • [24] Clofarabine ± Fludarabine with IV Busulfan and Allogeneic Stem Cell Transplantation for Advanced Myeloid Leukemia (ML) and MDS
    Chu, Diem
    Valdez, Ben C.
    Fox, Patricia S.
    Thall, Peter
    Worth, Laura
    Popat, Uday R.
    Jones, Roy B.
    Shpall, Elizabeth J.
    Hosing, Chitra
    Alousi, Amin M.
    Rondon, Gabriela
    Kebriaei, Partow
    Champlin, Richard E.
    Andersson, Borje S.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (02) : S152 - S153
  • [25] CLOFARABINE ± FLUDARABINE AND IV BUSULFAN WITH ALLOGENEIC STEM CELL TRANSPLANTATION FOR ADVANCED MYELOID LEUKEMIA (ML) AND MDS
    Andersson, B. S.
    Valdez, B. C.
    Thall, P. F.
    Wang, X.
    Worth, L. L.
    Popat, U.
    Alousi, A.
    Hosing, C.
    Jones, R. B.
    Shpall, E. J.
    de Lima, M.
    Champlin, R. E.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (02) : S293 - S293
  • [26] Busulfan Fludarabine (BU-FLU) Compared to Thiotepa Busulfan Fludarabine (TBF) for Allogeneic Transplants in Acute Myeloid Leukemia (AML) or Refractory Anemia with Excess Blasts (RAEB) in Remission
    Sora, Federica
    Sica, Simona
    Di Grazia, Carmen
    Chiusolo, Patrizia
    Laurenti, Luca
    Mordini, Nicola
    Olivieri, Attilio
    Iori, Anna Paola
    Angelucci, Emanuele
    Bacigalupo, Andrea
    BLOOD, 2017, 130
  • [27] Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for Pediatric Patients with Treatment Related Myelodysplastic Syndrome or Acute Myelogenous Leukemia (tMDS/AML)
    Kobos, Rachel
    Steinherz, Peter G.
    Kernan, Nancy A.
    Prockop, Susan E.
    Scaradavou, Andromachi
    Small, Trudy N.
    Shukla, Neerav
    Khalaf, Ramzi
    O'Reilly, Richard J.
    Boulad, Farid
    BLOOD, 2010, 116 (21) : 977 - 978
  • [28] Reduced-toxicity conditioning with treosulfan, fludarabine and ATG as preparative regimen for allogeneic stem cell transplantation (alloSCT) in elderly patients with secondary acute myeloid leukemia (sAML) or myelodysplastic syndrome (MDS)
    N Kröger
    A Shimoni
    T Zabelina
    H Schieder
    J Panse
    F Ayuk
    C Wolschke
    H Renges
    J Dahlke
    D Atanackovic
    A Nagler
    A Zander
    Bone Marrow Transplantation, 2006, 37 : 339 - 344
  • [29] Acute myeloid leukemia (AML) and Myelodysplastic syndrome (MDS) associated with Monosomy 7: Management by allogeneic hematopoietic stem cell transplantation (HSCT)
    Giller, RH
    Trobaugh, AD
    Hunger, SP
    Malcolm, J
    Schissel, D
    Hild, E
    Quinones, RR
    PEDIATRIC RESEARCH, 2002, 51 (04) : 251A - 251A
  • [30] Trends in hospitalization outcomes of elderly patients undergoing allogeneic stem cell transplantation for acute myeloid leukemia/myelodysplastic syndrome (AML/MDS).
    Murthy, Guru Subramanian Guru
    Mehta, Paulette
    Jethava, Yogesh
    Dhakal, Ishwori
    Makhoul, Issam
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
12345